| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Animal Science (R.M., N.L., R.M.), Faculty of Agriculture, Food and Environmental Quality Sciences, The Hebrew University of Jerusalem, Rehovot 76100, Israel; Department of Obstetrics and Gynecology (B.R., J.S.D.), Womens Research Institute, University of Kansas School of Medicine, Wichita, Kansas 67214; and VA Medical Center (B.R., J.S.D.), Wichita, Kansas 67214
Address all correspondence and requests for reprints to: Dr. Rina Meidan, Department of Animal Sciences, Faculty of Agriculture, Food and Environmental Quality Sciences, Hebrew University of Jerusalem, Rehovot 76100, Israel. E-mail: rina{at}agri.huji.ac.il
Our previous studies demonstrated that endothelin-1 (ET-1), a 21-amino
acid vasoconstrictor peptide, has a paracrine regulatory role in bovine
corpus luteum (CL). The peptide is produced within the gland where it
inhibits progesterone production by acting via the selective type A
endothelin (ETA) receptors. The present study was designed to
characterize ETA receptor gene expression in different ovarian cell
types and its hormonal regulation. ETA receptor messenger RNA (mRNA)
levels were high in follicular cells as well as in CL during luteal
regression. At this latter stage, high ETA receptor expression
concurred with low prostaglandin F2
receptor mRNA. The ETA receptor
gene was expressed by all three major cell populations of the bovine
CL; i.e. small and large luteal cells, as well as in
luteal endothelial cells. Among these various cell populations, the
highest ETA receptor mRNA levels were found in endothelial cells. cAMP
elevating agents, forskolin and LH, suppressed ETA receptor mRNA
expression in luteinized theca cells (LTC). This inhibition was
dose dependent and was evident already after 24 h of incubation.
In luteinized granulosa cells (LGC), 10 and 100 ng/ml of insulin-like
growth factor I and insulin (only at a concentration of 2000 ng/ml)
markedly decreased ETA receptor mRNA levels. In both LGC and LTC there
was an inverse relationship between ETA receptor gene expression and
progesterone production; insulin (in LGC) and forskolin (in LTC)
enhanced progesterone production while inhibiting ETA receptor mRNA
levels. Our findings may therefore suggest that, during early stages of
luteinization when peak levels of both LH and insulin-like growth
factor I exist, the expression of ETA receptors in the gland are
suppressed. This study demonstrates physiologically relevant regulatory
mechanisms controlling ETA receptor gene expression and further
supports the inhibitory role of ET-1 in CL function.
This article has been cited by other articles:
![]() |
C. Boiti, M. Maranesi, C. Dall'Aglio, L. Pascucci, G. Brecchia, A. Gobbetti, and M. Zerani Vasoactive Peptides in the Luteolytic Process Activated by PGF2alpha in Pseudopregnant Rabbits at Different Luteal Stages Biol Reprod, July 1, 2007; 77(1): 156 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boiti, G. Guelfi, G. Brecchia, C. Dall'Aglio, P. Ceccarelli, M. Maranesi, C. Mariottini, D. Zampini, A. Gobbetti, and M. Zerani Role of the Endothelin-1 System in the Luteolytic Process of Pseudopregnant Rabbits Endocrinology, March 1, 2005; 146(3): 1293 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Choudhary, A. Sen, E. K. Inskeep, and J. A. Flores Developmental Sensitivity of the Bovine Corpus Luteum to Prostaglandin F2{alpha} (PGF2{alpha}) and Endothelin-1 (ET-1): Is ET-1 a Mediator of the Luteolytic Actions of PGF2{alpha} or a Tonic Inhibitor of Progesterone Secretion? Biol Reprod, March 1, 2005; 72(3): 633 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Levy, M. Gordin, M. F. Smith, O. U. Bolden-Tiller, and R. Meidan Hormonal Regulation and Cell-Specific Expression of Endothelin-Converting Enzyme 1 Isoforms in Bovine Ovarian Endothelial and Steroidogenic Cells Biol Reprod, April 1, 2003; 68(4): 1361 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Levy, M. Gordin, R. Mamluk, M. Yanagisawa, M. F. Smith, J. H. Hampton, and R. Meidan Distinct Cellular Localization and Regulation of Endothelin-1 and Endothelin-Converting Enzyme-1 Expression in the Bovine Corpus Luteum: Implications for Luteolysis Endocrinology, December 1, 2001; 142(12): 5254 - 5260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Friedman, S. Weiss, N. Levy, and R. Meidan Role of Tumor Necrosis Factor {alpha} and Its Type I Receptor in Luteal Regression: Induction of Programmed Cell Death in Bovine Corpus Luteum-Derived Endothelial Cells Biol Reprod, December 1, 2000; 63(6): 1905 - 1912. [Abstract] [Full Text] |
||||
![]() |
J. A. Flores Gene Expression of Endothelin-1 in the Porcine Ovary: Follicular Development Biol Reprod, November 1, 2000; 63(5): 1377 - 1382. [Abstract] [Full Text] |
||||
![]() |
N. Levy, S.-i. Kobayashi, Z. Roth, D. Wolfenson, A. Miyamoto, and R. Meidan Administration of Prostaglandin F2{alpha} During the Early Bovine Luteal Phase Does Not Alter the Expression of ET-1 and of Its Type A Receptor: A Possible Cause for Corpus Luteum Refractoriness Biol Reprod, August 1, 2000; 63(2): 377 - 382. [Abstract] [Full Text] |
||||
![]() |
B.L. Sayre, R. Taft, E.K. Inskeep, and J. Killefer Increased Expression of Insulin-Like Growth Factor Binding Protein-1 During Induced Regression of Bovine Corpora Lutea Biol Reprod, July 1, 2000; 63(1): 21 - 29. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |